Latest Corporate News News
Brink's to Acquire NCR Atleos for $6.6 Billion
The Brink's Company announced a definitive agreement to acquire NCR Atleos in a cash and stock deal valued at $6.6 billion, including 13.3 million shares and $2.2 billion cash, plus assuming $2.6 billion debt. The deal offers a 24% premium over NCR Atleos' February 25 closing price and is expected to close in Q1 2027 pending approvals.
Post-closing, Brink's shareholders will own 78% of the combined entity.
Mistral AI Partners with Accenture on Enterprise AI Tech
French AI lab Mistral AI announced a multiyear partnership with Accenture to develop enterprise tech using Mistral’s models for clients. Accenture will become a Mistral customer and deploy its tech internally.
This follows similar Accenture deals with OpenAI and Anthropic, amid efforts to boost enterprise AI adoption.
Cemex Acquires Omega Products International
Cemex reached an agreement to acquire all assets of Omega Products International, a leading U.S. stucco manufacturer generating $23M annual EBITDA. Omega serves residential and commercial sectors with products from four facilities.
The JIAN Group represented Omega in the transaction.
Asahi Kasei Acquires Aicuris to Bolster Pharma Platform
Asahi Kasei entered a definitive agreement to acquire all shares of Aicuris Anti-infective Cures AG, strengthening its global pharmaceutical platform. The deal focuses on anti-infective therapies.
Announced on February 26, 2026.
Victory Capital Proposes Acquisition of Janus Henderson
Victory Capital affirmed its fully financed proposal to acquire Janus Henderson at $57.04 per share, a 37% premium to the unaffected price as of October 24, 2025. The bid aims to create a leading asset manager.
Details were released on February 26.
Blackbird Ventures Sells Eucalyptus to Hims & Hers for $1.15B
K&L Gates advised Blackbird Ventures on the $1.15 billion sale of Australian digital health firm Eucalyptus to Hims & Hers Health, Inc. Eucalyptus serves over 775,000 customers via telehealth for chronic disease management.
The deal is expected to close mid-2026 pending approvals.
Kairos Pharma Signs Term Sheet for Oncology Assets Acquisition
Kairos Pharma signed a term sheet to acquire worldwide rights to two clinical-stage oncology assets from Celyn Therapeutics, backed by OrbiMed. The assets target innovative cancer therapeutics.
Announcement made on February 26, 2026.
LENSAR Updates on Pending Alcon Acquisition
LENSAR expects its acquisition by Alcon to close in the first half of 2026, subject to ongoing regulatory review. The deal advances laser eye surgery technology.
Update provided amid continued approvals process.
LYTS Announces $325M Acquisition for Retail Solutions Growth
LYTS completed a $325 million acquisition to accelerate growth and form a leading retail solutions platform. The deal enhances market position in retail tech.
Reported on February 26, 2026.
World Bank Projects Global Growth Slowdown to 2.6% in 2026
Global growth is forecasted to slow to 2.6% amid weakening trade and intensifying tariff effects, per World Bank. WEF highlights uncertainty as the defining theme, with 50% expecting turbulence.
Business leaders cite workforce challenges, cyberattacks, and AI risks as top concerns.
EIC Launches Global Business Expansion Programme
The European Innovation Council unveiled its Global Business Expansion Programme for EIC-backed startups and SMEs, starting with South Korea. A launch webinar is set for February 27, 2026.
It offers market intelligence and support for international growth.